Equatorial Guinea vs Vanuatu: Hepatitis B surface antigen (HBsAg) prevalence
Equatorial Guinea
2.0%
in 2024
Vanuatu
1.8%
in 2024
Equatorial Guinea rank
12th
Vanuatu rank
13th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Equatorial Guinea
- Vanuatu
How they compare
Equatorial Guinea currently reports 2.0% against 1.8% in Vanuatu, a difference of 0.2%.
That makes Equatorial Guinea's figure about 1.1 times Vanuatu's.
Across all 10 years both countries report, Equatorial Guinea has been ahead every year.
Equatorial Guinea ranks 12th and Vanuatu ranks 13th of 194 countries.
Equatorial Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Equatorial Guinea | Vanuatu | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.3% | 1.6% | 0.7% | Equatorial Guinea |
| 2020s | 2.1% | 1.7% | 0.4% | Equatorial Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Equatorial Guinea or Vanuatu?
- Equatorial Guinea, at 2.0% against 1.8% in Vanuatu as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Equatorial Guinea and Vanuatu?
- 0.2%, with Equatorial Guinea ahead.
- How many years of comparable data are there for Equatorial Guinea and Vanuatu?
- 10 years are reported by both, from 2015 to 2024.
- How do Equatorial Guinea and Vanuatu rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Equatorial Guinea ranks 12th and Vanuatu ranks 13th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.